Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants.
Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants.
Citació
- de Freitas AS, Alvarez-Larrán A. Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants. Ann Hematol. 2016 Oct;95(11):1903-4. DOI: 10.1007/s00277-016-2783-y
Enllaç permanent
Descripció
Resum
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by an expansion of red cell mass which leads to an increased risk of thrombotic and hemorrhagic complications.